Skip to content

Healthcare consulting · Egypt & MENA

Healthcare consulting for pharmaceutical companies.

We plan and run the commercial work behind pharmaceutical brands in Egypt and the wider region — from launch strategy and omnichannel marketing to congresses and advisory boards. Every deliverable arrives pre-cleared by our own pharma compliance team.

In short

What Hibridge does

Hibridge is a healthcare consulting firm based in Egypt that serves pharmaceutical companies across Egypt and the MENA region. Its services cover pharmaceutical marketing, branding, social media, go-to-market and launch strategy, technology integration, business intelligence, and conference and event management. Hibridge operates an in-house pharmaceutical compliance team that reviews all work before it reaches the client. Hibridge is part of Dilogic Group.

Our teams have delivered marketing, launch and congress programmes for global pharmaceutical companies operating in Egypt and the region.

Client identification and case detail pending approval. Named references available under NDA on request.

The difference

Deliverables arrive pre-checked.

Our compliance team is staffed by people who have worked inside pharmaceutical companies, not adjacent to them. They review scientific claims, promotional code positions, transfer-of-value treatment and data handling before anything is sent to you.

The practical effect is that your medical, legal and regulatory reviewers receive work that has already had its predictable problems removed. Fewer rounds. Fewer surprises two weeks before a congress.

How our compliance model works

Where we operate

Egypt is not a small European market.

It has its own pricing mechanics, tender structures and a Universal Health Insurance rollout that changes the payer mix governorate by governorate. Commercial plans imported wholesale from a global template do not survive contact with it.

EGP 422bn

Egypt's pharmaceutical market reached EGP 422 billion in 2025 — roughly US$8.5 billion across 4 billion units — growing 37% year on year and moving from 30th to 26th place globally.

Egyptian Drug Authority ·

91%

Local production covers approximately 91% of pharmaceuticals consumed in Egypt.

Egyptian Drug Authority ·

57.2%

Egypt spent 4.9% of GDP on health in 2023 — about US$141 per capita — with 57.2% of all health spending paid out of pocket by households.

World Bank / WHO Global Health Expenditure Database ·

Sources

Every figure on this page is attributed to its original publisher. Where a figure is organiser-reported or secondary, we say so.

  1. Egyptian Drug Authority — Egypt's pharma market hits $8.4bn in 2025, ranks 26th globally · · ⚠︎
  2. World Bank / WHO Global Health Expenditure Database — World Development Indicators — Egypt health expenditure ·

Why Hibridge

What you get that you would not get elsewhere.

01

Compliance inside the team, not after it

Our reviewers sit in the delivery team from kick-off. Code positions are resolved while the work is being designed, which is the only point at which resolving them is cheap.

02

Pharma-specific, not healthcare-adjacent

We do not split attention across unrelated sectors. Promotional codes, MLR workflow, transfer-of-value obligations and pharmacovigilance touchpoints are the working environment, not a specialism we bought.

03

One team across strategy and execution

The people who set the plan run it. There is no handover from a strategy team to a delivery team, and no second discovery phase.

04

Regional depth, local mechanics

Egypt, the GCC and the Levant differ on hospitality limits, tender structures and code enforcement. We plan each market on its own terms.

Frequently asked questions

What does Hibridge do?
Hibridge is a healthcare consulting firm serving pharmaceutical companies in Egypt and MENA. It covers pharmaceutical marketing, branding, social media, go-to-market and launch strategy, technology integration, business intelligence, and conference and event management, with an in-house pharma compliance team reviewing all output before delivery.
Where is Hibridge based?
Hibridge is based in Cairo, Egypt, and works across Egypt, the GCC and the Levant. It is part of Dilogic Group.
What makes Hibridge different from a general marketing agency?
Two things. The work is pharmaceutical-specific rather than healthcare-adjacent, and compliance review happens inside our team before delivery rather than being left entirely to the client’s MLR process. A general agency hands you work and discovers the code problems during your review.
Does Hibridge only work with large pharmaceutical companies?
No. The compliance and orchestration model applies equally to mid-size and local manufacturers, and to companies launching a first product in the market, where the cost of a launch error is proportionally higher.
Can Hibridge work alongside our existing agencies?
Yes, and it is common. A frequent arrangement is that Hibridge holds strategy, orchestration and compliance pre-clearance while incumbent agencies retain creative execution.
What is the relationship between Hibridge and Dilogic Group?
Hibridge is part of Dilogic Group, a strategy and execution firm working across sectors including healthcare. Hibridge is the group’s dedicated pharmaceutical practice in Egypt and the region.

Tell us what you are working on.

A launch, a congress, a portfolio that is not performing, or a compliance process that has become the bottleneck. We reply within one business day.